Corrections to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection

On June 29, 2015, the following updates were made to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (released March 5, 2015):

• In the Abacavir and Lamivudine sections, Triumeq was added to the Panel Recommendations. Additionally, the weight band dosing tables in these sections were updated to match the most recent Food and Drug Administration recommendations.
• In the Atazanavir section, the footnote of the Pharmacokinetic Parameters for Atazanavir table was revised and the data was updated based on atazanavir sulfate (Reyataz) product information.